Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 31, Issue 9, Pages 1494-1501
Publisher
Oxford University Press (OUP)
Online
2015-11-25
DOI
10.1093/ndt/gfv393
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of High-Flux Dialysis on Circulating FGF-23 Levels in End-Stage Renal Disease Patients: Results from a Randomized Trial
- (2015) Andreas Schneider et al. PLoS One
- Changes in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients?
- (2015) Esmée M. Ettema et al. PLoS One
- Acute Hemodynamic Response and Uremic Toxin Removal in Conventional and Extended Hemodialysis and Hemodiafiltration: A Randomized Crossover Study
- (2014) Tom Cornelis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The Use of Fibroblast Growth Factor 23 Testing in Patients with Kidney Disease
- (2014) E. R. Smith Clinical Journal of the American Society of Nephrology
- Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4
- (2014) S. Seiler et al. Clinical Journal of the American Society of Nephrology
- FGF23 regulates renal sodium handling and blood pressure
- (2014) Olena Andrukhova et al. EMBO Molecular Medicine
- Impact of hemodialysis, left ventricular mass and FGF-23 on myocardial mechanics in end-stage renal disease: a three-dimensional speckle tracking study
- (2014) Attila Kovács et al. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
- Lower serum fibroblast growth factor-23 levels may suggest malnutrition in maintenance haemodialysis patients
- (2014) Sonoo Mizuiri et al. NEPHROLOGY
- Effects of fluid overload on heart rate variability in chronic kidney disease patients on hemodialysis
- (2014) Manuela Ferrario et al. BMC Nephrology
- Fibroblast Growth Factor–23 and Cardiac Structure and Function
- (2014) Isha Agarwal et al. Journal of the American Heart Association
- Fibroblast Growth Factor 23 and Cardiovascular Mortality after Kidney Transplantation
- (2013) L. C. Baia et al. Clinical Journal of the American Society of Nephrology
- Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients
- (2013) Shailendra Sharma et al. CLINICAL NEPHROLOGY
- Correlates of left ventricular mass in chronic hemodialysis recipients
- (2013) Ron Wald et al. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
- Sympathetic Activation Induces SkeletalFgf23Expression in a Circadian Rhythm-dependent Manner
- (2013) Masanobu Kawai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
- (2013) J. J. Scialla et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pulmonary Congestion Predicts Cardiac Events and Mortality in ESRD
- (2013) C. Zoccali et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Phosphate handling by end-stage kidneys and benefits of residual renal function on phosphate removal in patients on haemodialysis
- (2013) Hideaki Iwasawa et al. NEPHROLOGY
- Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis
- (2013) J. Zaritsky et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23, High-Sensitivity Cardiac Troponin, and Left Ventricular Hypertrophy in CKD
- (2012) Kelsey Smith et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Interactions between calcium and phosphorus in the regulation of the production of fibroblast growth factor 23 in vivo
- (2012) Stephen J. Quinn et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Correction of Plasma Concentrations for Effects of Hemoconcentration or Hemodilution
- (2012) Daniel Schneditz et al. ASAIO JOURNAL
- Association of Circulating Fibroblast Growth Factor-23 with Renal Phosphate Excretion among Hemodialysis Patients with Residual Renal Function
- (2012) M. Wang et al. Clinical Journal of the American Society of Nephrology
- Modifiable Practices Associated with Sudden Death among Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study
- (2012) M. Jadoul et al. Clinical Journal of the American Society of Nephrology
- Hemodialysis-Induced Regional Left Ventricular Systolic Dysfunction: Prevalence, Patient and Dialysis Treatment-Related Factors, and Prognostic Significance
- (2012) S. Assa et al. Clinical Journal of the American Society of Nephrology
- Changes in circulating biomarkers during a single hemodialysis session
- (2012) Tae Yamamoto et al. Hemodialysis International
- Biological Variability of Plasma Intact and C-Terminal FGF23 Measurements
- (2012) Edward R. Smith et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
- (2012) Victoria Shalhoub et al. JOURNAL OF CLINICAL INVESTIGATION
- FGF-23 removal is improved by on-line high-efficiency hemodiafiltration compared to conventional high flux hemodialysis
- (2012) Laure Patrier et al. JOURNAL OF NEPHROLOGY
- Effects of Frequent Hemodialysis on Measures of CKD Mineral and Bone Disorder
- (2012) J. T. Daugirdas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast Growth Factor 23 in Patients Undergoing Peritoneal Dialysis
- (2011) T. Isakova et al. Clinical Journal of the American Society of Nephrology
- The phosphatonin fibroblast growth factor 23 links calcium–phosphate metabolism with left-ventricular dysfunction and atrial fibrillation
- (2011) Sarah Seiler et al. EUROPEAN HEART JOURNAL
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients
- (2011) L. Viaene et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality
- (2010) Jennifer E. Flythe et al. KIDNEY INTERNATIONAL
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
- (2009) G. Jean et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The mortality risk of overhydration in haemodialysis patients
- (2009) Volker Wizemann et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started